KIR2DL4 (CD158d): An activation receptor for HLA-G

Area of Science:

• Immunology
• Cell Biology
• Reproductive Biology

Background:

• Killer cell immunoglobulin-like receptors (KIRs) are key regulators of immune responses.
• KIR2DL4 is a unique member of the KIR family with distinct structural and signaling properties.
• KIR2DL4 is expressed on natural killer (NK) cells and T cells, and its only known ligand is HLA-G.

Purpose of the Study:

• To elucidate the unique cellular localization and signaling pathway of KIR2DL4.
• To investigate the functional consequences of KIR2DL4 engagement by its ligand, HLA-G.
• To explore the role of KIR2DL4 in the context of early pregnancy.

Main Methods:

• Analysis of KIR2DL4 expression and localization in immune cells.
• Investigation of KIR2DL4 signaling pathways involving DNA-PKcs and Akt kinases.
• Study of the interaction between KIR2DL4 and HLA-G in vitro and in vivo models.

Main Results:

• KIR2DL4, unlike other KIRs, resides in endosomes and signals from this intracellular compartment.
• Engagement of KIR2DL4 activates NK cells for cytokine and chemokine secretion, not cytotoxicity.
• The novel endosomal pathway involves DNA-PKcs and Akt kinases.
• KIR2DL4-HLA-G interaction promotes proinflammatory and proangiogenic responses.

Conclusions:

• KIR2DL4 utilizes a unique endosomal signaling pathway for immune modulation.
• The interaction between KIR2DL4 and HLA-G plays a significant role in maternal vascular remodeling during early pregnancy.
• KIR2DL4 is a critical mediator of immune adaptation in the maternal-fetal interface.